Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Cash & Equivalents (2016 - 2025)

National Healthcare Properties (HLTC) has 13 years of Cash & Equivalents data on record, last reported at $57.6 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 166.12% year-over-year to $57.6 million; the TTM value through Dec 2025 reached $57.6 million, up 166.12%, while the annual FY2025 figure was $57.6 million, 166.12% up from the prior year.
  • Cash & Equivalents reached $57.6 million in Q4 2025 per HLTC's latest filing, up from $21.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $74.1 million in Q1 2021 and bottomed at $21.7 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $46.4 million, with a median of $46.4 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: plummeted 63.78% in 2021, then skyrocketed 166.12% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $59.7 million in 2021, then fell by 10.18% to $53.7 million in 2022, then decreased by 13.5% to $46.4 million in 2023, then plummeted by 53.35% to $21.7 million in 2024, then surged by 166.12% to $57.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $57.6 million in Q4 2025, $21.7 million in Q4 2024, and $32.9 million in Q3 2024.